This company is no longer active
InDex Pharmaceuticals Holding Gestione
Gestione criteri di controllo 2/4
InDex Pharmaceuticals Holding's CEO is Jenny Sundqvist, appointed in Jan 2023, has a tenure of 1.42 years. total yearly compensation is SEK3.54M, comprised of 64% salary and 36% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth SEK65.60K. The average tenure of the management team and the board of directors is 4.6 years and 8.4 years respectively.
Informazioni chiave
Jenny Sundqvist
Amministratore delegato
SEK 3.5m
Compenso totale
Percentuale dello stipendio del CEO | 64.0% |
Mandato del CEO | 1.4yrs |
Proprietà del CEO | 0.02% |
Durata media del management | 4.6yrs |
Durata media del Consiglio di amministrazione | 8.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost
Jun 13Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce
Apr 28We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate
Jul 11We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth
Jan 21We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth
Aug 31Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation
Mar 29InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.
Feb 04How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?
Dec 21Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -SEK 56m |
Dec 31 2023 | SEK 4m | SEK 2m | -SEK 95m |
Compensazione vs Mercato: Jenny's total compensation ($USD338.03K) is above average for companies of similar size in the Swedish market ($USD256.68K).
Compensazione vs guadagni: Insufficient data to compare Jenny's compensation with company performance.
AMMINISTRATORE DELEGATO
Jenny Sundqvist (53 yo)
1.4yrs
Mandato
SEK 3,543,000
Compensazione
Ms. Jenny Sundqvist serves as Chief Executive Officer of InDex Pharmaceuticals Holding AB (publ) since January 01, 2023. She served as Chief Commercial Officer of Isofol Medical AB (publ) from January 1, 2...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Chief Executive Officer | 1.4yrs | SEK 3.54m | 0.023% SEK 65.6k | |
Deputy CEO & Chief Financial Officer | 7.1yrs | SEK 2.80m | 0.073% SEK 209.8k | |
Chief Scientific Officer | 2.1yrs | Nessun dato | 0.0017% SEK 4.9k | |
Head of Regulatory Affairs | 11.4yrs | Nessun dato | Nessun dato |
4.6yrs
Durata media
56yo
Età media
Gestione esperta: INDEX's management team is considered experienced (4.6 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Independent Director | 13.4yrs | SEK 235.00k | 0.081% SEK 232.4k | |
Independent Director | 8.4yrs | SEK 235.00k | 0.077% SEK 219.5k | |
Director | less than a year | Nessun dato | Nessun dato | |
Member of Advisory Board - North America | no data | Nessun dato | Nessun dato | |
Member of Advisory Board - Europe | no data | Nessun dato | Nessun dato | |
Independent Chairman | 13.4yrs | SEK 500.00k | 0.14% SEK 406.6k | |
Member of Advisory Board - Europe | no data | Nessun dato | Nessun dato | |
Chairman of Advisory Board - Europe | 2yrs | Nessun dato | Nessun dato | |
Member of Advisory Board - Europe | no data | Nessun dato | Nessun dato | |
Member of Advisory Board - Europe | no data | Nessun dato | Nessun dato | |
Member of Advisory Board - Europe | no data | Nessun dato | Nessun dato | |
Member of Advisory Board - North America | no data | Nessun dato | Nessun dato |
8.4yrs
Durata media
70yo
Età media
Consiglio di amministrazione esperto: INDEX's board of directors are considered experienced (8.4 years average tenure).